Frontiers in Cardiovascular Medicine

MARCH 20, 2025

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral Stenosis 52

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). 2.44];P=0.035).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

American College of Cardiology

OCTOBER 21, 2024

Patients with moderate or severe tricuspid regurgitation (TR) prior to undergoing TAVR or mitral transcatheter edge-to-edge repair (TEER), when compared to patients with no or mild TR, were associated with worse health status and clinical outcomes, according to a study published in JACC: Cardiovascular Interventions.

TAVR 46

TAVR Bicuspid/Mitral Tricuspid Outcomes 46

Circulation

OCTOBER 23, 2024

BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aortic valve replacement (SAVR) in patients with bicuspid aortic valve (BAV) aortic stenosis (AS) versus patients with tricuspid aortic valve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Journal of the American Heart Association

APRIL 10, 2025

BackgroundBicuspid aortic valves are associated with ascending aortic pathology, but their impact on longterm outcomes, including aortic growth and adverse events, remains unclear.Methods and ResultsThis prospective cohortstudy included adult patients undergoing aortic valve surgery or ascending aortic surgery at a single center (20072013).

Aortic valve 51

Aortic valve Aortic Bicuspid/Mitral Tricuspid 51

DAIC

FEBRUARY 21, 2024

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. million Americans have moderate to severe tricuspid regurgitation. to receive the device.

Heart Failure 105

Heart Failure Open-Heart Surgery Tricuspid Heart Disease 105

Medical Xpress - Cardiology

MARCH 13, 2025

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors. It is also frequently observed in AFMR patients, making it crucial to understand its impact on AFMR outcomes.

Tricuspid 40

Tricuspid Heart Failure Bicuspid/Mitral Heart Disease 40

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid 40

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves 40

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. 7.33],P=0.02).ConclusionsThe

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Risk Factors Tricuspid 40

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. Single-arm studies, conference presentations, animal studies, and studies that involved patients with tricuspid aortic morphology were excluded. Medical databases were queried to pool comparative studies of interest. to 4.58, p=0.04).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

CardiacWire

JANUARY 31, 2024

In the first study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting , researchers analyzed outcomes from 37k California-based patients who underwent SAVR or TAVR between 2013 to 2021… Of the 2,360 patients under the age of 60, 22% received TAVR and 78% received SAVR. to 54.5%), but declined among 65-79yr (49.2%

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

The American Journal of Cardiology

MAY 2, 2024

Publication date: Available online 1 May 2024 Source: The American Journal of Cardiology Author(s): Srinivasa Potluri

Tricuspid 40

Tricuspid Bicuspid/Mitral Outcomes 40

DAIC

AUGUST 27, 2024

Enabling a wide variety of qualified physicians to quickly and accurately diagnose these conditions at the bedside could lead to earlier detection and treatment, and better patient outcomes, as well as greater efficiencies and cost savings to health systems, while ultimately saving countless lives.”

Ultrasound 98

Ultrasound Tricuspid Bicuspid/Mitral Aortic 98

The American Journal of Cardiology

APRIL 10, 2024

Publication date: Available online 9 April 2024 Source: The American Journal of Cardiology Author(s): Hiroki A. Ueyama, Giancarlo Licitra, Patrick T. Gleason, Omid Behbahani-Nejad, Roshan Modi, Dhiren Rajagopal, Isida Byku, Joe X. Xie, Adam B. Greenbaum, Gaetano Paone, W. Brent Keeling, Kendra J. Grubb, George S. Hanzel, Chandan M.

Tricuspid 40

Tricuspid Bicuspid/Mitral Outcomes 40

DAIC

APRIL 16, 2024

Van Mieghem for treating the first patient in this study and look forward to following the outcomes from other patients in this study.” Currently, there are no sutureless options available for vessel closure following large-bore venous procedures. I’m grateful to Prof.

Technology 105

Technology Interventional Cardiology Tricuspid Bicuspid/Mitral 105

The American Journal of Cardiology

DECEMBER 4, 2024

Publication date: Available online 4 December 2024 Source: The American Journal of Cardiology Author(s): Sarah C. Ashley, Muhammad Shahzeb Khan, Stephen J.

Heart Failure 40

Heart Failure Tricuspid Bicuspid/Mitral Outcomes 40

European Journal of Heart Failure

FEBRUARY 26, 2025

We propose management pathways to optimize HFrEF treatment in the context of low BP, ultimately aiming to improve patient outcomes. Low blood pressure with major or mild symptoms. **SBP SBP <80mmHg or symptomatic low BP or asymptomatic low BP.

Blood Pressure 58

Blood Pressure Heart Failure Aortic valve TAVR 58

Open Heart

APRIL 24, 2023

Cardiologists favoured routine postoperative echocardiography in all patients (44%), whereas cardiothoracic surgeons preferred routine imaging after specific procedures, especially mitral (85%) and tricuspid (79%) valve surgery. Overall, pericardiocentesis (83%) was preferred over surgical evacuation (17%).

Cardiothoracic 52

Cardiothoracic Tricuspid Bicuspid/Mitral Hospital 52

DAIC

FEBRUARY 18, 2025

Previous studies about heart valve disease have focused on procedural or device outcomes, and less on patient-centered and disease-related outcomes that are relevant to patients physical and mental well-being and quality of life. tim.hodson Tue, 02/18/2025 - 16:41 Feb. tim.hodson Tue, 02/18/2025 - 16:41 Feb.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

ADN Center of Excellence

MAY 28, 2024

Our tour kicked off in the picturesque city of Antalya, where the Mediterranean Health Foundation (ASV) Life Hospital graciously hosted the first session, a Mitral and Tricuspid Valve Hands-on led by the esteemed Assoc. Ismail Ates and Dr. Zeynettin KAYA. www.adncoe.com

Interventional Cardiology 52

Interventional Cardiology Hospital Tricuspid Bicuspid/Mitral 52

Dr. Smith's ECG Blog

JULY 22, 2012

Blunt cardiac injury my result in : 1) Acute myocardial rupture with tamponade 2) Valve rupture (tricuspid, aortic, mitral) 3) Coronary thrombosis or dissection (and thus Acute MI) from direct coronary blunt injury 4) Dysrhythmias of all kinds. If it had been, could this outcome have been anticipated? And, then, so what?

Dysrhythmia 52

Dysrhythmia Biomarkers Echocardiogram Ultrasound 52

Journal of the American Heart Association

APRIL 11, 2025

In patients with ischemic mitral regurgitation undergoing surgery, data on the exercise assessment of the right ventricularPA coupling are not available. In patients with ischemic mitral regurgitation the exercise right ventricular PA coupling could improve risk stratification. P&lt;0.01). Larger studies are needed.

Exercise 40

Exercise Bicuspid/Mitral Outcomes Pulmonary 40

Heart BMJ

APRIL 15, 2024

Objective Variants in the FLNA gene have been associated with mitral valve dystrophy (MVD), and even polyvalvular disease has been reported. This study aimed to analyse the aortic valve and root involvement in FLNA -MVD families and its impact on outcomes. The outcomes were defined as aortic valve surgery or all-cause mortality.

Bicuspid/Mitral 52

Bicuspid/Mitral Aortic valve Aortic Heart Valves 52

Open Heart

SEPTEMBER 1, 2023

Objective A substantial proportion of patients with rheumatic heart disease (RHD) have tricuspid regurgitation (TR). This study aimed to identify the impact of functional TR on clinical outcomes and predictors of progression in a large population of patients with RHD. and severe in 4.3%. for moderate, and 2.30 (95% CI 1.28

Tricuspid 52

Tricuspid Bicuspid/Mitral Outcomes Echocardiogram 52

Journal of Cardiovascular Electrophysiology

FEBRUARY 20, 2025

ABSTRACT Background The impact of tricuspid regurgitation (TR) on the outcomes of pulmonary vein isolation (PVI) for atrial fibrillation (AF) remains unclear. Further multicenter, prospective studies are required to validate these results and explore long-term outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Tricuspid Pulmonary Bicuspid/Mitral 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Heart BMJ

DECEMBER 13, 2024

Background Significant secondary mitral regurgitation (SMR) is known to be associated with worse prognosis. In the present study, clinical and echocardiographic parameters associated with outcomes were evaluated in a large cohort of patients with moderate SMR.

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Pulmonary Tricuspid 52

Heart BMJ

APRIL 25, 2024

The primary composite outcome of death or heart failure hospitalisation was evaluated among these patients. years, the composite outcome was met in 89 patients (43%). In multivariable analysis, peak aortic jet velocity (Vmax) was independently and inversely associated with the composite outcome (HR: 0.63, 95% CI 0.43 –1.5

Aortic valve 52

Aortic valve Aortic Outcomes Myocardial Infarction 52

European Journal of Heart Failure

JANUARY 8, 2025

Abstract Aims Secondary mitral regurgitation (SMR) and tricuspid regurgitation (TR) are the most common valvular heart diseases in patients with heart failure (HF). Abstract Aims Secondary mitral regurgitation (SMR) and tricuspid regurgitation (TR) are the most common valvular heart diseases in patients with heart failure (HF).

Heart Failure 76

Heart Failure Bicuspid/Mitral Tricuspid Document 76

Dr. S. Venkatesan MD

JANUARY 6, 2025

This happens in spite of normal mitral leaflets and intrinsically normal mitral valve apparatus. Image source : Barbara Brzeziska and Krystyna oboz-Grudzie from the Book : Structural Insufficiency Anomalies in Cardiac Valves Mechanism of functional mitral regurgitation. (A) Why fight with nomenclature ? 2019 ) Reference 1.

Bicuspid/Mitral 52

Bicuspid/Mitral Tricuspid Academic Circulation 52

European Journal of Heart Failure

DECEMBER 19, 2024

AF, atrial fibrillation; LAVI, left atrial volume index; RA, right atrial; RV, right ventricular; sPAP, systolic pulmonary artery pressure; SVI, stroke volume index; TR, tricuspid regurgitation. RVD was common and associated with a significantly higher all-cause mortality after TAVI.

Stenosis 40

Stenosis Aortic Pulmonary Aortic valve 40